IL17A and rheumatoid arthritis: In addition, 1,25(OH)2D modulates Th17 polarization in early RA patients, down-regulating IL-17A, IL-17F, TNFα, and IL-22 expression, and stimulating IL-4 that exerts anti-inflammatory effects (13).